328 results on '"Kelly, Colleen R."'
Search Results
2. Decision
3. AGA Clinical Practice Guideline on Fecal Microbiota–Based Therapies for Select Gastrointestinal Diseases
4. Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry
5. Redefining Clostridioides difficile infection antibiotic response and clinical outcomes
6. Effectiveness and Safety of Colonic and Capsule Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection
7. Long-term Outcomes Following Multiply Recurrent Clostridioides difficile Infection and Fecal Microbiota Transplantation
8. Donor Screening for Fecal Microbiota Transplantation in China: Evaluation of 8483 Candidates
9. Outcomes After Fecal Microbiota Transplantation in Combination With Bezlotoxumab for Inflammatory Bowel Disease and Recurrent Clostridioides difficile Infection.
10. Review Article: Gastroenterology and Clostridium difficile Infection: Past, Present, and Future
11. Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation
12. Risk Factors that Predict the Failure of Multiple Fecal Microbiota Transplantations for Clostridioides difficile Infection
13. Patients Eligible for Trials of Microbe-Based Therapeutics Do Not Represent the Population With Recurrent Clostridioides difficile Infection
14. 655. Analysis of Microbiome Diversity and Secondary Bile Acid Synthesis Following SER-109 or Placebo in Patients with First Recurrent or Multiply Recurrent Clostridioides difficile Infection
15. S1207 Clinical Decision Making in Mimickers of IBD: Practice Management From IBD Live
16. S2524 Intussusception From a Giant Colon Lipoma
17. S2280 A Twisted Tale: Sigmoid Volvulus Secondary to Rectal Stricture
18. S3861 A Rare Case of Linezolid-Induced Acute Liver Failure
19. S2559 Colocolic Fistula Due to Severe Constipation
20. Nuts and Bolts of Fecal Microbiota Transplantation
21. Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection
22. The 5D framework: a clinical primer for fecal microbiota transplantation to treat Clostridium difficile infection
23. Fecal Transplant in Inflammatory Bowel Disease
24. Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection
25. 221. Assessment and Proposed Revision of Clinical Trial Clostridioides difficile Infection Clinical Response and Outcomes Definitions
26. A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection
27. Annals for Hospitalists Inpatient Notes - Clinical Pearls—Updates on Clostridioides difficile Infection for Hospitalists
28. Reply.
29. Effectiveness and Safety of Fecal Microbiota Transplantation for Clostridioides Difficile Infection: Results From a 5344-Patient Cohort Study
30. Guidance on Preparing an Investigational New Drug Application for Fecal Microbiota Transplantation Studies
31. FMT in IBD: What Have We Learned?
32. Su1603: ANTICIPATED IMPACT OF LIVE BIOTHERAPEUTIC PRODUCTS ON FECAL MICROBIOTA TRANSPLANTATION (FMT) PRACTICE
33. Tu1519: CP101, AN INVESTIGATIONAL MICROBIOME THERAPEUTIC FOR THE PREVENTION OF RECURRENT C. DIFFICILE INFECTION: A COMBINED ANALYSIS OF THE PRISM3 (RANDOMIZED PLACEBO-CONTROLLED) AND PRISM-EXT (OPEN-LABEL) TRIALS
34. 583: CP101, AN INVESTIGATIONAL ORALLY ADMINISTERED MICROBIOME THERAPEUTIC, WAS EFFECTIVE FOR PREVENTION OF RECURRENT C. DIFFICILE INFECTION: RESULTS FROM OPEN-LABEL PRISM-EXT TRIAL
35. Su1607: PRE-FMT ANTIBIOTIC USE IS ASSOCIATED WITH HIGHER RATES OF CURE AFTER FECAL MICROBIOTA TRANSPLANTATION FOR RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION
36. Transient Flare of Ulcerative Colitis After Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
37. Hair Growth in Two Alopecia Patients after Fecal Microbiota Transplant
38. Response to McFarland et al.
39. Weight Gain After Fecal Microbiota Transplantation
40. Correction to: ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections
41. S3341 When It Is Not Inflammatory Bowel Disease: IBD Mimics Presented at IBD Live
42. S144 CP101 Engraftment Drives Efficacy: Results From a Randomized, Placebo-Controlled Trial Evaluating CP101, an Investigational Orally Administered Microbiome Therapeutic for Prevention of Recurrent C. difficile Infection
43. S180 Disparities in Access to FMT at a Tertiary Care Center
44. S146 Donor Screening for Fecal Microbiota Transplantation in China: Evaluation of 8,483 Candidates
45. S2754 Refractory Hyperammonemic Encephalopathy Cured With Levocarnitine Infusions
46. S3644 Nivolumab-Induced Liver Injury
47. S131 CP101, an Investigational Orally Administered Microbiome Therapeutic, Increases Intestinal Microbiome Diversity and Prevents Recurrent C. difficile Infection: Results From a Randomized, Placebo-Controlled Trial
48. SARS-CoV-2 vaccines and donor recruitment for FMT
49. Reply
50. ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.